NB PHARMA
0465.917.724 · rovalta.com · 24/09/2026
NB PHARMA
Overview
What does NB PHARMA do?
NB PHARMA is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Nieuwpoort. It employs on average 1,8 ETP workers (FTE).
8620 Nieuwpoort · FlandreSee on map
Joint committees (1)
- 313
Trend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2008 | 2007 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||
| Gross margin | 272,3 k € | -8.2% | 296,7 k € | +16.1% | 255,6 k € | +310239% | -82,4 € | +69.1% | -266,7 € | -100% | 58,4 k € | -37.0% | 92,7 k € |
| EBITDA | 107,6 k € | +15.2% | 93,4 k € | +22.5% | 76,2 k € | +14169% | -541,9 € | +31.9% | -796,1 € | -102% | 45,3 k € | -13.6% | 52,4 k € |
| Operating result | 71,2 k € | +19.5% | 59,6 k € | +48.0% | 40,2 k € | +7526% | -541,9 € | +31.9% | -796,1 € | -105% | 15 k € | -33.4% | 22,4 k € |
| Net result | 56,7 k € | +19.3% | 47,5 k € | +28.2% | 37,1 k € | +4410% | 822,2 € | +555% | -180,8 € | -102% | 11 k € | -23.5% | 14,4 k € |
| Balance sheet | |||||||||||||
| Equity | 574 k € | +11.0% | 517,2 k € | +10.1% | 469,7 k € | +328% | 109,7 k € | +0.8% | 108,8 k € | +126% | 48,1 k € | +11.7% | 43,1 k € |
| Total assets | 745,5 k € | +11.1% | 670,8 k € | +5.3% | 637,3 k € | +481% | 109,8 k € | +0.8% | 109 k € | -52.4% | 228,9 k € | -5.5% | 242,2 k € |
| Cash | 13,2 k € | +57.7% | 8,4 k € | -62.7% | 22,5 k € | – | 2 k € | -95.3% | 42,2 k € | +165% | 15,9 k € | ||
| Debts | 171,6 k € | +11.7% | 153,5 k € | -8.4% | 167,6 k € | +149505% | 112 € | +0.9% | 111 € | -99.9% | 180,8 k € | -9.2% | 199,2 k € |
| Other | |||||||||||||
| Workforce | 1,8 ETP | -30.8% | 2,6 ETP | +23.8% | 2,1 ETP | – | – | 0,3 ETP | -66.7% | 0,9 ETP | |||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 9 ended
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/07/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 6 months |
| Filing date | 12/05/2026 | 17/06/2025 | 13/06/2024 | 09/06/2023 | 07/06/2022 | 17/06/2021 |
| General meeting | 03/04/2026 | 04/04/2025 | 05/04/2024 | 07/04/2023 | 01/04/2022 | 02/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
21 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 03/04/2026 | 12/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 04/04/2025 | 17/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 05/04/2024 | 13/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 07/04/2023 | 09/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/04/2022 | 07/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 02/04/2021 | 17/06/2021 | Dutch | |
| Micro model | 30/06/2020 | 28/09/2020 | 27/10/2020 | Dutch | |
| Micro model | 30/06/2019 | 31/12/2019 | 28/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 31/12/2018 | 23/01/2019 | Dutch | |
| Abridged model | 30/06/2017 | 30/12/2017 | 29/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 30/12/2016 | 30/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 12/12/2015 | 11/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 29/12/2014 | 14/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 05/01/2014 | 29/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 05/01/2013 | 30/01/2013 | Dutch | |
| Abridged model | 30/06/2011 | 30/12/2011 | 30/01/2012 | Dutch | |
| Abridged model | 30/06/2010 | 11/12/2010 | 07/01/2011 | Dutch | |
| Abridged model | 30/06/2009 | 12/12/2009 | 13/01/2010 | Dutch | |
| Abridged model | 30/06/2008 | 07/01/2009 | 22/01/2009 | Dutch | |
| Abridged model | 30/06/2007 | 05/01/2008 | 14/01/2008 | Dutch | |
| Abridged model | 30/06/2006 | 06/01/2007 | 31/01/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Belgian Official Gazette publications
- Mandates17/07/2026ONTSLAGEN - BENOEMINGEN
- Registered office10/08/2023MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Restructuring11/05/2023RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates09/12/2022ONTSLAGEN - BENOEMINGEN
- Mandates03/05/2021ONTSLAGEN - BENOEMINGEN
- Mandates25/11/2020ONTSLAGEN - BENOEMINGEN
- Mandates05/10/2020WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
- Capital / shares16/03/2007KAPITAAL - AANDELEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202556,7 k €↑
- 2024Annual accounts 202447,5 k €↑
- 2024Name change057 - NB Pharma
- 2023Annual accounts 202337,1 k €↑
- 2022Annual accounts 2022822,2 €↑
- 2021Annual accounts 2021-180,8 €↓
- 2021Name changeNB Pharma
- 2008Annual accounts 200811 k €↓
- 2007Annual accounts 200714,4 k €
- 20/04/1999IncorporationPrivate limited company